Evidence map›Paper›PMID 29131162›Full record

ArticleNature methods2017

The 3D OrbiSIMS-label-free metabolic imaging with subcellular lateral resolution and high mass-resolving power.

Melissa K Passarelli, Alexander Pirkl, Rudolf Moellers, Dmitry Grinfeld, Felix Kollmer, Rasmus Havelund, Carla F Newman, Peter S Marshall, Henrik Arlinghaus, Morgan R Alexander and 6 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature methods, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 186 papers.

0numbers the graph read from it
0cells of the map it votes in
186citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

186 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Advances in spatial omics for the analysis of prostate cancer.Analytical and bioanalytical chemistry · 2026
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Glycosaminoglycans and Their Role in Capillary Walls.Advances in experimental medicine and biology · 2026
    Review

126 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Melissa K PassarelliNational Physical Laboratory, NiCE-MSI, Teddington, Middlesex, UK.
Alexander PirklION-TOF GmbH, Münster, Germany.
Rudolf MoellersION-TOF GmbH, Münster, Germany.
Dmitry GrinfeldThermo Fisher Scientific, Bremen, Germany.
Felix KollmerION-TOF GmbH, Münster, Germany.
Rasmus HavelundNational Physical Laboratory, NiCE-MSI, Teddington, Middlesex, UK.ORCID http://orcid.org/0000-0001-7316-9761
Carla F NewmanGlaxoSmithKline, Stevenage, UK.
Peter S MarshallGlaxoSmithKline, Stevenage, UK.
Henrik ArlinghausION-TOF GmbH, Münster, Germany.ORCID http://orcid.org/0000-0002-9351-3141
Morgan R AlexanderSchool of Pharmacy, The University of Nottingham, Nottingham, UK.ORCID http://orcid.org/0000-0001-5182-493X
Andy WestGlaxoSmithKline, Stevenage, UK.
Stevan HorningThermo Fisher Scientific, Bremen, Germany.
Ewald NiehuisION-TOF GmbH, Münster, Germany.ORCID http://orcid.org/0000-0001-8158-8974
Alexander MakarovThermo Fisher Scientific, Bremen, Germany.
Colin T DolleryGlaxoSmithKline, Stevenage, UK.
Ian S GilmoreNational Physical Laboratory, NiCE-MSI, Teddington, Middlesex, UK.ORCID http://orcid.org/0000-0002-0981-2318

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We report the development of a 3D OrbiSIMS instrument for label-free biomedical imaging. It combines the high spatial resolution of secondary ion mass spectrometry (SIMS; under 200 nm for inorganic species and under 2 μm for biomolecules) with the high mass-resolving power of an Orbitrap (>240,000 at m/z 200). This allows exogenous and endogenous metabolites to be visualized in 3D with subcellular resolution. We imaged the distribution of neurotransmitters-gamma-aminobutyric acid, dopamine and serotonin-with high spectroscopic confidence in the mouse hippocampus. We also putatively annotated and mapped the subcellular localization of 29 sulfoglycosphingolipids and 45 glycerophospholipids, and we confirmed lipid identities with tandem mass spectrometry. We demonstrated single-cell metabolomic profiling using rat alveolar macrophage cells incubated with different concentrations of the drug amiodarone, and we observed that the upregulation of phospholipid species and cholesterol is correlated with the accumulation of amiodarone.

Indexed as

AmiodaroneAnimalsCells, CulturedDopamineEquipment DesignFemalegamma-Aminobutyric AcidGlycerophospholipidsHippocampusImaging, Three-DimensionalMacrophages, AlveolarMetabolomicsMiceMolecular ImagingSensitivity and SpecificitySerotoninAmiodaroneDopaminegamma-Aminobutyric AcidGlycerophospholipidsSerotoninSulfoglycosphingolipids

Identifiers

PMID29131162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.